TMRW Life Sciences Raises $105M in Funding

22 Jul, 2021

TMRW Life Sciences Raises $105M in Funding
Photo by Raphael Koh on Unsplash

– TMRW Life Sciences, Inc., a NYC-based life sciences technology company providing an automated platform for tracking, monitoring, and storage of frozen eggs and embryos used in in vitro fertilization (IVF), completed a $105m Series C equity and debt financing.
– The equity round was led by Transformation Capital with participation from GV (formerly Google Ventures), Casdin Capital, Peter Thiel, Anne and Susan Wojcicki, and existing investors 5AM Ventures and Life Sciences Innovation Fund, among others.
– The company intends to use the funds to accelerate global expansion, advance product innovation, develop consumer awareness of the platform, and support future business development opportunities.

Biotechnology Health Care Life Science North America
Crunchbase icon

Content report

The following text will be sent to our editors: